Evidence map›Paper›PMID 28573251›Full record

ArticleAfrican journal of traditional, complementary, and alternative medicines : AJTCAM2017

MORIN MITIGATES OXIDATIVE STRESS, APOPTOSIS AND INFLAMMATION IN CEREBRAL ISCHEMIC RATS.

Yanrong Chen, Yanke Li, Huali Xu, Gang Li, Yunxia Ma, Yu Jun Pang

Open access · diamondAbstract read
In one paragraph

Article in African journal of traditional, complementary, and alternative medicines : AJTCAM, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yanrong ChenDepartment of Neurology, Binzhou city central hospital, Binzhou, Shandong 251700, China.
Yanke LiDepartment of Neurology, Binzhou city central hospital, Binzhou, Shandong 251700, China.
Huali XuDepartment of Neurology, Binzhou city central hospital, Binzhou, Shandong 251700, China.
Gang LiDepartment of Neurology, Binzhou city central hospital, Binzhou, Shandong 251700, China.
Yunxia MaDepartment of Neurology, Binzhou city central hospital, Binzhou, Shandong 251700, China.
Yu Jun PangDepartment of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Binzhou People's Hospital · CNHarbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMorin is a flavanoid which exhibits potent antioxidant activity in various oxidative stress related diseases. The current study was attempted to scrutinize the preclinical bio-efficacy of morin on focal ischemia.

methodsThe animal model of focal cerebral ischemic injury was done by midbrain carotid artery occlusion (MCAO) method, followed by Morin (30mg/kg) administration for seven days.

resultsThe outcome of the study showed that treatment with morin displayed positive effects in reducing the focal cerebral ischemia. This effect was evident with the improvements in neurological deficits, reduction in MDA content and elevation of antioxidant levels (SOD, GSH and Gpx). Furthermore, protein expression of Bax and caspase-3 were effectively down-regulated, whilst the expression of Bcl-2 was significantly elevated. On the other hand, the mRNA expression of proinflammatory cytokines was significantly reduced in focal cerebral ischemic rats upon morin intervention.

conclusionThus, the beneficial effects of morin on cerebral ischemia assault may result from the reduction of oxidative stress, inhibition of apoptosis and inflammation. The neuroprotective effects of morin supplement may serve as potent adjuvant in the amelioration of ischemic stroke.

Indexed as

PhytotherapyAnimalsAnti-Inflammatory AgentsAntioxidantsApoptosisBrain IschemiaCytokinesDisease Models, AnimalFlavonesFlavonoidsInflammationMaleOxidative StressPlant ExtractsRats, Sprague-DawleyRNA, MessengerAnti-Inflammatory AgentsAntioxidantsCytokinesFlavonesFlavonoidsmorinPlant ExtractsRNA, MessengerapoptosisFocal cerebral ischemiainflammationlipid peroxidationmorinoxidative stress

Identifiers

PMID28573251
PMCPMC5446461
OpenAlexW2588307679

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.